ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $448,000 | +58.9% | 4,824 | +2.0% | 0.02% | +50.0% |
| Q3 2021 | $282,000 | -12.7% | 4,729 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $323,000 | -1.5% | 4,729 | 0.0% | 0.01% | -7.7% |
| Q1 2021 | $328,000 | -12.3% | 4,729 | -2.9% | 0.01% | -23.5% |
| Q4 2020 | $374,000 | +1.9% | 4,870 | -0.7% | 0.02% | 0.0% |
| Q3 2020 | $367,000 | +18.8% | 4,905 | 0.0% | 0.02% | +13.3% |
| Q2 2020 | $309,000 | +62.6% | 4,905 | +8.4% | 0.02% | +36.4% |
| Q1 2020 | $190,000 | -4.5% | 4,525 | +3.1% | 0.01% | +22.2% |
| Q4 2019 | $199,000 | +5.3% | 4,389 | +6.0% | 0.01% | 0.0% |
| Q3 2019 | $189,000 | -22.2% | 4,139 | 0.0% | 0.01% | -18.2% |
| Q2 2019 | $243,000 | +30.6% | 4,139 | 0.0% | 0.01% | +22.2% |
| Q1 2019 | $186,000 | +15.5% | 4,139 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $161,000 | -15.3% | 4,139 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $190,000 | +5.6% | 4,139 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $180,000 | +11.8% | 4,139 | +1.4% | 0.01% | +12.5% |
| Q1 2018 | $161,000 | +41.2% | 4,080 | +21.8% | 0.01% | +60.0% |
| Q4 2017 | $114,000 | +93.2% | 3,350 | +29.4% | 0.01% | +66.7% |
| Q3 2017 | $59,000 | +34.1% | 2,588 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $44,000 | – | 2,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |